13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-08-05 Event 2026-08-03 SEC 0001753037-26-000003 →

5AM Ventures VI, L.P. CAMP4 THERAPEUTICS CORPORATION CAMP

Stake: 9.90% Shares: 2,625,145 CUSIP: 13463J101 Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 9.10
1,442,275 shares short · +10.0% vs prior

Other 13D/G Filings on CAMP4 THERAPEUTICS CORPORATION

FiledFormFilerStakeShares
2025-09-15 SCHEDULE Enavate Sciences GP, LLC 8.10% 3,785,802 view →

Other Filings by 5AM Ventures VI, L.P.

FiledFormIssuerStakeShares
2023-08-28 SC Enliven Therapeutics, Inc. ELVN view →
2023-02-28 SC CinCor Pharma, Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →